---
title: "Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286263022.md"
description: "Wedbush analyst Laura Chico has maintained a Buy rating on PepGen Inc. (PEPG) with a price target of $4.00. Chico, a 5-star analyst, has an average return of 13.2% and a success rate of 52.03%. The analyst consensus for PepGen Inc. is Moderate Buy, with a price target consensus of $10.17."
datetime: "2026-05-13T12:37:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286263022.md)
  - [en](https://longbridge.com/en/news/286263022.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286263022.md)
generator: "portal-rs"
---

# Wedbush Keeps Their Buy Rating on PepGen Inc. (PEPG)

Wedbush analyst Laura Chico maintained a Buy rating on PepGen Inc. today and set a price target of $4.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

According to TipRanks, Chico is a 5-star analyst with an average return of 13.2% and a 52.03% success rate. Chico covers the Healthcare sector, focusing on stocks such as Viridian Therapeutics, Ovid Therapeutics, and Maze Therapeutics, Inc..

PepGen Inc. has an analyst consensus of Moderate Buy, with a price target consensus of $10.17.

### Related Stocks

- [PEPG.US](https://longbridge.com/en/quote/PEPG.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VRDN.US](https://longbridge.com/en/quote/VRDN.US.md)
- [OVID.US](https://longbridge.com/en/quote/OVID.US.md)
- [MAZE.US](https://longbridge.com/en/quote/MAZE.US.md)

## Related News & Research

- [Guotai Asset Management sees liquidity boost driving China biotech, innovation drug shares higher](https://longbridge.com/en/news/296448906.md)
- [Moderna surges on trial win for cancer shot; William Blair upgrades](https://longbridge.com/en/news/296370751.md)
- [SBIO: U.S. Programmatic and EMEA drove 49% of Q2 sales, with margins rising to 61% and profitability expected in H2 2026](https://longbridge.com/en/news/296517769.md)
- [LIVE MARKETS-BofA clients flock to tech stocks](https://longbridge.com/en/news/296383193.md)
- [U.S. kindergarten vaccine coverage falls, CDC says](https://longbridge.com/en/news/296136711.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**